Literature DB >> 10601576

Stimulation of insulin release in hereditarily diabetic rats by mixed molecules formed of nateglinide and a succinic acid ester.

L Ladriere1, F Bjorkling, W J Malaisse.   

Abstract

Hereditarily diabetic Goto-Kakizaki rats were infused for 5 min with saline, containing as required nateglinide or mixed molecules (HD154 and HD166) with both a nateglinide moiety and a succinic acid ester moiety. The dose of these agents given intravenously amounted to 5.0 nmol/g body weight in all cases. All agents provoked a comparable early increase in plasma insulin concentration. However, HD154 and HD166, but not nateglinide itself, also caused a secondary rise in plasma insulin concentration 30 min after their infusion. It is proposed that mixed molecules formed of both a hypoglycemic sulfonylurea or meglitinide analog and a succinic acid ester may be better able than the antidiabetic agents themselves to evoke a sustained stimulation of insulin release in non-insulin-dependent diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10601576     DOI: 10.3892/ijmm.5.1.63

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  3 in total

1.  Comparison of selective versus dual endothelin receptor antagonism on cerebrovascular dysfunction in diabetes.

Authors:  Weiguo Li; Kamakshi Sachidanandam; Adviye Ergul
Journal:  Neurol Res       Date:  2011-03       Impact factor: 2.448

2.  Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.

Authors:  Alex K Harris; Mostafa M Elgebaly; Weiguo Li; Kamakshi Sachidanandam; Adviye Ergul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-02-20       Impact factor: 3.619

3.  Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.

Authors:  Kamakshi Sachidanandam; Mostafa M Elgebaly; Alex K Harris; Jim R Hutchinson; Erin M Mezzetti; Vera Portik-Dobos; Adviye Ergul
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-18       Impact factor: 4.733

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.